US 11236161
Chimeric antigen receptors targeting CD-19
granted A61KA61K2239/13A61K2239/31
Quick answer
US patent 11236161 (Chimeric antigen receptors targeting CD-19) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2239/13, A61K2239/31, A61K2239/48, A61K40/11